Gastroenterology

RESEARCH WORK AND PUBLICATIONS

(National and International)

1989

1. A study of “Congestive Cardiomyopathy” Rawal Med. Jr. Vol. 17,22,1989.
2. Diabetic foot, study of 25 cases 1989

1992

3. Rare in not so rare (Study of Syphilis). Pak. Jr. Obstet. Gynaecol. Vol.5, No. 1,1992.
4. Peripartum Cardiomyopathy Journal Pak. Jr. Obstet Gynecology Vol. 5. No.1,1992.
5. Evaluation of Coronary Artery Risk Factors in Premenopausal Women. Pak. Jr. Obstet. Gynaecol. Vol.5, No. 1, 1992.
6. Group B Streptococci Carriage in Pregnant Women. Pak. Jr. Obstet. Gynaecol. Vol.5, No.1, 1992.

1995

7. Non Tropical Sprue (Coelic Disease) and Iron deficiency Anemia. Pakistan journal of Gastroenterology Vol. 9. No.1, 1995.
8. Association of H. Pylori with Chronic Gastritis. Pakistan journal of Gastroenterology Vol. 9 . No.1, 1995.
9. Incidence of poisoning in women of Rawalpindi during 1997 Pak. Jr. Obstet. Gynaecol Vol.11 No.1, 1995.

1998

10. Manual: Dealing with Hepatitis C. Diagnosis & Treatment Guide; 1998.
11. Urdu Book “Hepatitis A, B, C for Patient Education and Awareness”, 1998
12. Association of dudenitis with duodenal ulcer-Digestion, World Congress UEGW Vienna Austria 1998.
13. Incidence of homicidal deaths in women in Rawalpindi during 1997. Pak, Jr. Obstet, Gynecology Vol.11 No, 1,2, & 3 1998.
14. Evaluation of helico bacter pylori in esophagitis Pak J. Gastroenterology; September 1998.
15. Clinical Spectrum of Liver Disease due to HBV, HCV and dual infection. A comparative Study; Pak Journal of Gastroenterology; September 1998.

1999

16. Snake bite: a study of 50 cases. J Rawal Med Coll 1999; 3(1&2): 40-2.
17. Manual “Training of Specialist/Staff of Autonomous Hospital of Punjab Health Department, Punjab; 1999.

2000

18. Book: An evidence based approach Diagnosis and management of Hepatitis C, May, 2000.

2001

19. Hepatology in Pakistan: Past, Present and Future Editorial JRMC July-Dec, 2001
20. Clinical spectrum of patients with esophageal, gastric and colonic carcinomas in Rawalpindi Islamabad region, JRMC Vol. 5(2) July-Dec, 2001
21. Association of Child-Pugh class with patterns of mortality in hepatitis C virus related chronic liver disease, JRMC Vol. 5(2) July-Dec, 2001.
22. Sero-prevalence of Liver Disease in Diabetes Mellitus, JRMC Vol. 5(2) July-Dec, 2001.
23. Sero-prevalence of Hepatitis B and C viruses in Hepatocellular Carcinoma, JRMC Vol. 5(2) July-Dec, 2001.
24. Demographic features of Hepatocellular Carcinoma: A Study of 30 cases, JRMC Vol. 5(2) July-Dec, 2001.
25. Non Alcoholic Steato-hepatitis (NASH), JRMC Vol. 5(2) July-Dec, 2001(Abstract)
26. Transjuglar Intrahepatic Porto-systemic Shunt (TIPS) Vol. 5(2) 2001.
27. Spectrum of CLD due to HCV infection. ACG USA Vol. 96 No. 9 September 2001.
28. An experience of cirrhotic hepatic encephalopathy at DHQ Teaching Hospital, Rawalpindi. JRMC2001; 5(2): 60-4.
29. Treatment of chronic myeloid leukemia: recent advances. J Rawal Med Coll 2001; 5(1):41-5.
30. Alveolar microlithiasis in a Kashmiri family. J Coll Physicians Surg Pak 2001; 11(2):110-3.

2002

31. Self-inflicted injuries: the standing medical board experience. J Coll Physicians Surg Pak 2002; 12(9): 518-21.
32. Acute myocardial infarction: experience at a teaching hospital. J Rawal Med Coll 2002; 6(2): 65-9.
33. Brochioalveolar carcinoma. J Coll Physicians Surg Pak 2002; 12(2): 125-7.
34. Evaluation of lymphocytic pleural effusion with pleural biopsy. J Coll Physicians Surg Pak 2002; 12(2): 74-7.
35. Evaluation of cardiac denervation in patients with long-standing diabetes. J Coll Physicians Surg Pak 2002; 12(1): 12-5.
36. Guidelines for purification of water and common use medical equipments for doctors and public, Oct 2002.
37. Manual of “Burden of Liver Diseases in Teaching hospitals of RMC from 1998-2001 (Four Years) May 2002.
38. An analysis of 8000 endoscopies in teaching hospital of RMC in JPSP).July 2002
39. Hypocellular myelodysplastic syndrome presenting as megaloblastic anemia. J Ayub Med Coll Abbottabad. 2002 Jul-Sep;14(3):29-30. PubMed PMID: 12476862.

2003

40. Management of Chronic Hepatitis B: Combination Therapy-A Future Promise. Pak J. Gastroentrerol Vol.17 No.1, March 2003
41. Pattern of esophageal varices and portal gastropathy in HCV related cirrhosis. Pakistan Journal of Gastroenterology-S Vol.17 No.1, March 2003
42. Evaluation of HCV anti-bodies among family contacts of HCV related Chronic Liver Disease patients. Pakistan Journal of Gastroenterology-S Vol.17 No.1, March 2003
43. Clinical spectrum of Non-Alcoholic Steatohepatitis (NASH) in non-Diabetic population. Pakistan Journal of Gastroenterology-S Vol.17 No.1, March 2003
44. Endoscopic and histopathological evaluation of 306 dyspeptic patients. Pakistan Journal of Gastroenterology-S Vol.17 No.1, March 2003
45. A 12-year Audit of upper gastrointestinal Endoscopic procedures, JCPSP Vol.13 No.6, June 2003.
46. Practice Guidelines on Hepatitis A, B, C and E in Pakistan August 2003.
47. Endoscopic evaluation of 2484 patients with upper GI hemorrhage. J Rawal Med Coll 2003; 7(2): 89-92.
48. Prevalence of anti-HCV antibodies among health care workers of Rawalpindi and Islamabad. Rawal Med J 2003; 28: 7-11.
49. Endoscopic retrograde cholangiopancreatographic evaluation of patients with obstructive jaundice. J Coll Physicians Surg Pak 2003; 13(6): 325-8.
50. A 12 years audit of upper gastrointestinal Endoscopic procedures. J Coll Physicians Surg Pak 2003; 13(6): 321-4.
51. Upper GI Endoscopic evaluation of 299 patients with clinically compensated cirrhosis. Pak J Gastroenterology 2003; 17(1): 12-6.

2004

52. Pakistan Society of Gastroenterology (PSG) guidelines for treatment of Hepatitis B & C. Journal of Pakistan Medicine Association. April 2004.
53. NASH in non-diabetes Pakistani Population, AGA Supplement 68^th Annual Scientific Meeting. Oct 13-15, 2004. Baltimore Maryland USA.
54. Unusual Complication (Paraplegia) after Ethanolamine Injection Sclerotherapy for Varices. American Journal Gastroenterology Supplement Oct 2004..
55. Characteristic features of 50 NAFLD patients. Rawal Med J 2004; 29: 8-12.
56. Clinical spectrum of non-alcoholic Steatohepatitis (NASH) in non diabetic population. J Gastroenterology and Hepatology 2004; 19(suppl): A833.
57. Anti-HCV antibody status of various sections of Pakistani population and patients. J Gastroenterology and Hepatology 2004; 19(suppl): A720.

2005

58. Extracorporeal shock wave lithotripsy. J Coll Physicians Surg Pak 2005; 15(10):638-41.
59. Emergency department evaluation of patients with chest pain, J Rawal Med Coll 2005; 9(1):22-5.

2006

60. Obesity related complications in 100 obese subjects and their age matched controls. J Pak Med Assoc 2006; 56(2): 50-3.
61. Association of platelet count to splenic index ratio with presence of esophageal Varices in patients with HCV related compensated cirrhosis.Pak J Gastroenterology 2006; 20(1):37-43.
62. Histopathological evaluation of esophageal columnarized mucosa in gastro esophageal reflux disease. Pak J Gastroenterology 2006; 20(1): 11-3.
63. Utility of Mantoux test in the diagnosis of tuberculosis. JRMC 2006; 10(1):12-9.
64. Helicobacter pylori genetic profile of dyspeptic patients: perspective from Rawalpindi, Pakistan. Pak J Gastroenterology 2006; 20(1): 6-10.
65. Acute hepatitis E: experience at Holy Family Hospital, Rawalpindi. Pak J Gastroenterology 2006; 20(1): 32-6.
66. Characteristics of Chronic Hepatitis C, 3a Patients who did not respond to Therapy with Interferon and Ribavirin. Pak J Gastroenterology 2006; 20(1): 55-7.
67. Peg-Interferon, Ribavirin, Thymosin Alpha-1 and Amantadine (Quadruple Therapy) in Chronic Hepatitis C3a Patients who are Non-responders to Interferon-alpha plus Ribavirin. Pak J Gastroenterology 2006; 20(1): 18-24.
68. Knowledge of Hepatitis C among Primary Care Doctors Working in Allied Hospitals of Rawalpindi Medical College, Rawalpindi. Pak J Gastroenterology 2006; 20(1):63-71.
69. Chronic Hepatitis C: Symptoms and Their Response to Combination Therapy with Interferon and Ribavirin. Pak J Gastroenterology 2006; 20(1): 49-54.
70. Hematological Changes in Viral Hepatitis [Abstract]. J Rawal Med Coll 2006; 10(Suppl):58
71. Frequency of Barrett’s Esophagus in Dyspeptic Patients on Endoscopy: a prospective and retrospective survey carried out in Rawalpindi and Islamabad [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 58-9.
72. Liver Transplant: Post-transplant Complications and Follow-up: a Local Experience [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 60.
73. Poor Response of Pegylated Interferon in Patients of Chronic Hepatitis C after Treatment Failure with Conventional Interferon Therapy [Abstract]. J Rawal Med Coll 2006; 10 (Suppl):61.
74. Response Pattern of Conventional Interferon Therapy in Chronic Active Hepatitis [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 61-2.
75. Comparison of CTP and MELD Score for predicting the short-term mortality in end stage liver disease (ESLD) Hospitalized Patients in Rawalpindi / Islamabad [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 62-3.
76. Patterns of abnormal lfts in viral hepatitis [Abstract]. J Rawal Med Coll 2006; 10 (Suppl):63.
77. A study of demographic features of patients with chronic liver disease and type 2 diabetes mellitus [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 64.
78. Sero-prevalence of Dual Hepatitis B and C Infection among 536 Tested Patients [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 64-5.
79. To Study the Frequency of Portal Gastropathy in Patients Presenting with Upper GI Bleed on Endoscopy [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 65-6.
80. In Chronic HBV Patients with Raised ALT Level, the Presence of HBeAg should be considered a Surrogate Marker of HBV DNA [Abstract]. J Rawal Med Coll 2006; 10 (Suppl):66.
81. Trends of Use of Alternative Medicine in Chronic Hepatitis Patients Presenting to a Hospital in Rawalpindi [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 67.
82. Evaluation of Patterns of Serological Markers in Asymptomatic Hepatitis B Patients [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 68.
83. To evaluate Prevalence and Relevance of Hyponatremia with Encephalopathy in Cirrhotic Patients [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 68-9.
84. Use of N-Acetylcysteine an Acute Liver Failure (Non Paracetamol Iduced): an ITC Experience [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 69.
85. Knowledge, Attitude and Practices of Medical Students towards Hepatitis B and C [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 70.
86. Association of Laboratory and Clinical Variable with Short-term Mortality in Patients with End Stage Liver Disease [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 71.
87. Etiological Prevalence of Acute Upper Gastrointestinal Hemorrhage [Abstract]. J Rawal Med Coll 2006; 10 (Suppl): 78.
88. Pakistan Society of Gastroenterology. Management of variceal bleeding: PSG guidelines 2006. J Pak Med Assoc. 2007 Oct;57(10):505-11. Review. PubMed PMID: 17990427.

2007

89. Etiological Pattern and Outcome in Acute Liver Failure [Abstract O-0219]. Hep Intl 2007; 1(1): 40.
90. First Experience of Pakistani Liver Transplant Patients: Where Do We Stand? [Abstract O-0249]. Hep Intl 2007; 1(1): 45.
91. Symptomatology of Chronic Hepatitis C [Abstract P-0397]. Hep Intl 2007; 1(1): 142.
92. Chronic Hepatitis C Symptoms and Their Response to Combination Therapy [Abstract P-0442]. Hep Intl 2007; 1(1): 149.

2008

93. The Frequency of Serological Markers of HBV Infection in Asymptomatic Pakistan Patients. [Abstract 343]. AJG 2008; 103(51) 5133
94. Mid Treatment Thyroid Profile Abnormalities in Conventional Interferon Treated Chronic Hepatitis C Patients. [Abstract 344]. AJG 2008; 103(51) 5133

2009

95. HCV Genotype Distribution in Chronic Hepatitis C patients in Tertiary Care Hospital of Rawalpindi Medical College [Abstract PE363] Hep Intl 2009 3 (1): 173.
96. Prevalence of Hepatitis C in Pakistan, Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
97. Endoscopic Variceal Band Ligation in Chronic Liver Disease patients: Experience at Holy Family Hospital, Rawalpnidi. Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
98. Histological Outcome Of Liver Biopsies In Patients with Chronic Hepatitis C, A Local Experience, Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
99. Results from The National Program for Prevention and Control of Hepatitis C – A Pakistani Perspective, Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
100. Does Histologic Activity Index (HAI) and ALT level Predict Response to Treatment For Hepatitis C with Conventional Interferon Alpha and Ribavarin? Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
101. Risk Factors for HCV Infection in Pakistan, Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
102. Treatment Outcome for HCV Genotype 3 With Standard Interferon Alpha and Ribavarin – Experience From a Tertiary Care Hospital in Pakistan, Am J Gastroenterol, Volume 104, Issue S3 (October 2009)
103. Anti HCV antibody positivity of various sections of Pakistan patients, Journal of College of Physicians and Surgeons Pakistan 2009 Vol 19 (11) 737-741

2011

104. Factors affecting the rate of fibrosis and their significance in HCV infection APASL 2011 Hep Intl 2011
105. To compare the virological responses in Naïve hepatitis C patients treated with conventional interferon/ribavirin and peglylated interferon/ribavirin APASL 2011 Hep Intl 2011
106. To determine the prevalence and impact of previous HBV infection in chronic hepatitis C patients treated with conventional interferon/ribavirin APASL 2011 Hep Intl 2011
107. To study the endoscopic pattern of portal hypertensive changes and their correlation with liver histology in chronic hepatitis c patients APASL 2011 Hep Intl 2011

 2012

108. Correlation of serum alanine transaminase with levels of viremia in chronic hepatitis c patients APASL 2012
109. Comparison of different staging models for hepatocellular carcinoma (HCC) in terms of outcome APASL 2012
110. 5 year survival rates of patients with HCV related end stage liver disease after liver transplantation APASL 2012
111. Endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of mediastinal and abdominal lesions APASL 2012
112. Extent of liver inflammation in predicting 3 response to interferon α & Ribavirin in chronic 4 hepatitis C patients: a cohort study, BMC Gastroenterology, 2012, 12:71

2013

113. HBV Perinatal Transmission International Journal of Hepatology Volume 2013 (2013)
114. HCV related HCC in Pakistan APASL 2013
115. “Propofol plus Midazolam versus Propofol alone Sedation In Therapeutic ERCP, JRMC July – December, 2013
116. Frequently isolated bacteria and their culture and sensitivity pattern in a medical ICU. J Coll Physicians Surg Pak. 2013 Sep;23(9):681-2. doi: 09.2013/JCPSP.681682. PubMed PMID: 24034202.

2014

117. Early Predictability of Virological Response In Patients Of Chronic Hepatitis-C With Genotype-3,Treated With Pegylated Interferon And Ribavirin J Ayub Med Coll Abbottabad 2014;26(4)

2015

118. Effect of previous exposure to HBV on Liver Histology and Treatment Response in CHC patients, JCPSP, 2015 Vol 25(7) 498-500. PubMedPMID: 26208552.

2016

119. Ultrasonographic pattern of plasma leak in dengue hemorrhagic fever, JPak Med Assoc, Vol.66, No.3, March2016, PMID: 26968273
120. Management of Adult Dengue Shock Syndrome Patients Not improving with DEAG Guidelines Based Therapy, Journal of Rawalpindi Medical College (JRMC) 2016-20-1-2-6
121. New Direct Acting Antiviral Agents For The Treatment Of Hepatitis C: 2016 And Beyond JCPSP October 2016, Vol :26, No.10
122. Sofosbuvir for the treatment of Hepatitis C Genotype 3 infected patients in Pakistan (Original Article) J Ayub Med Coll Abbottabad 2016;28(4 Suppl 1)
123. Issues Pertaining to DAAs J Ayub Med Coll Abbottabad 2016;28(4 Suppl 1)
124. Role of Generics in treatment of Hepatitis C infection(Review Article) J Ayub Med Coll Abbottabad 2016;28(4 Suppl 1)
125. National Consensus Practice Guidelines – Diagnosis, Management and Prevention of Hepatitis C in Pakistan 2017, J Ayub Med Coll Abbottabad 2016;28(4 Suppl 1)

2018

126. Assessment of Serum Alt Levels In Chronic Hepatitis C Patients In Accordance With Gender, International Annals of Internal Medicine Journal 2018 (Accepted)

INTERNATIONAL PUBLICATIONS

1. Umar M, Bushra HT, Ahmad M, Data A, Ahmad M, Khurram M, Usman S, Arif M, Adam T, Minhas Z, Arif A, Naeem A, Ejaz K, Butt Z, Bilal M “Hepatitis C in Pakistan A review of available data, Hepatitis Monthly 2010 IRAN, 10(3) 205-214, IRAN”
2. Umar M, Hamama-Tul-Bushra, Umar S, Khan HA, “HBV Perinatal Transmission International Journal of Hepatology Volume 2013 (2013) ID 875791, USA”
3. Umar M, Khan AG, Abbas Z, Arora S, Asifabbas N, Elewaut A, Esmat G, Foster G, Fried M, Goh KL, Hamama TB, Imawari M, Isakov V, Krabshuis J, LaBrecque D, Lemair A, Malfertheiner P, Ryder S, Schiedermaier P, Stimac D, Tandon R, Villamil F, Zapata R, Ferenci P, “World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013. J Clin Gastroenterol. 2014 Mar;48(3):204-17. doi: 10.1097/MCG.0000000000000050. PubMed PMID: 24504078, USA”
4. Khan HA, Umar M, Tul-Bushra H, Nisar G, Bilal M, Umar S “Safety Of Non-Anaesthesiologist-Administered Propofol Sedation In ERCP, Arab J Gastroenterol. 2014 Mar;15(1):32-5. doi: 10.1016/j.ajg.2014.01.011. Epub 2014 Feb 18, NETHERLANDS”
5. Haider Ali Khan, Muhammad Umar, Masood Ahmed, Hamama-tul-Bushra, Gul Nisar, “Safety Of Non-Anesthesiologists Administered Propofol Sedation In EUS, Euroasian Journal of Hepato-Gastroenterology, July-December 2013;3(2):85-88, BANGLADESH”
6. ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P. “Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two dose schedule. Vaccine, 2003 July 4;21(23):3179-85, JAPAN”
7. Gul Nisar, Hamama-Tul-Bushra Khaar,  Muhammad Umar,  Tayyab S. Akhter,  Muhammad Khurram, Mohammad Bilal,  Shifa Umar, “Post ERCP complications: Comparing standard biliary cannulation with needle knife fistulotomy May 2015 Volume 81, Issue 5, Supplement, Page AB409, DDW 2015 Washington DC, USA”
8. Khurram M, Faheem M, Umar M, Yasin A, Qayyum W, Ashraf A, Zahid Khan J, Hasnain Yasir A, Ansari Y, Asad M, Khan I, Abbas S, Rasheed I, Rasool N, Bushra Khar HT, “Hemophagocytic Lymphohistiocytosis Complicating Dengue and Plasmodiumvivax Coinfection. Case Rep Med. 2015;2015:696842. doi: 10.1155/2015/696842. Epub2015 Oct 4. PubMed PMID: 26504465; PubMed Central PMCID: PMC4609418.USA”
9. Mirza S, Siddiqui AR, Hamid S, Umar M, Bashir S. “Extent of liver inflammation in predicting 3 response to interferon α& Ribavirin in chronic 4 hepatitis C patients: a cohort study, BMC Gastroenterology, 2012, 12:71, UK”
10. Review Team, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Peñaranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, Umar M, Krabshuis J, LeMair A “World Gastroenterology Organisation Global Guidelines: Nonalcoholic fatty liver disease and nonalcoholic steato-hepatitis. J Clin Gastroenterol. 2014 Jul;48(6):467-73. doi: 10.1097/MCG.0000000000000116. PubMed PMID: 24921212. USA”
11. Taha M, Tanaka J, Tarifi H, Tayyab G, Ud Din M, Umar M, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Blach S. “Strategies to manage hepatitis C virus infection disease burden – volume 3. J Viral Hepat. 2015 Dec;22Suppl 4:42-65. doi: 10.1111/jvh.12474. PubMed PMID: 26513447. USA”
12. Liakina V, Hamid S, Tanaka J, Olafsson , Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Gunter J. “Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3. J Viral Hepat. 2015 Dec;22 Suppl 4:4-20. doi: 10.1111/jvh.12475. PubMed PMID: 26513445. USA”
13. Sibley A, Han KH, Abourached A, Lesmana LA, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Schmelzer JD. “The present and future disease burden of hepatitis C virus infections with today’s treatment paradigm – volume 3. J Viral Hepat. 2015 Dec;22 Suppl 4:21-41. doi: 10.1111/jvh.12476. PubMed PMID: 26513446. USA”
14. Khurram M, Qayyum W, Hassan SJ, Mumtaz S, Bushra HT, Umar M, “Comparison of patients with primary and secondary infections. J Infect Public Health. 2014 Nov-Dec;7(6):489-95. doi:10.1016/j.jiph.2014.05.005. Epub 2014 Jul 4. PubMed PMID: 24999118. SAUDI ARABIA”
15. “World Gastroenterology Organisation Global Guidelines: Diagnosis, Management and Prevention of Hepatitis C Update 2017, (Journal of Clinical Gastroenterology) http://www.worldgastroenterology.org/guidelines/global-guidelines/hepatitis-c/hepatitis-c-english
16. Umar M, Tayyab SA, Sadiq J, Saleem S, Khokhar S, Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients – a real life experience  from Pakistan, Hepatoma Res2018;4:71, 2019, USA
17. Spectrum of Hepatocellular Carcinoma: A Study From Center For Liver And Digestive Diseases, Holyfamily Hospital, Pakistan, WGO International Conference, Gastro 2018 Bangkok, (Abstract)
18. Efficacy of Generic Velpatasvir+Sofosbuvir in treatment of genotype 3 infected Hepatitis C patients. A real life experience from Pakistan (Abstract Accepted APASL 2019)